Inhibition of the STAT3 signaling pathway is involved in the antitumor activity of cepharanthine in SaOS2 cells

Formation, recognition and bioactivities of a novel G-quadruplex in the STAT3 gene

(2011) Sen Lin et al.   BIOORGANIC & MEDICINAL CHEMISTRY LETTERS

Targeting inflammatory pathways for tumor radiosensitization

(2010) Amit Deorukhkar et al.   BIOCHEMICAL PHARMACOLOGY

Oleanane triterpenoid CDDO-Me induces apoptosis in multidrug resistant osteosarcoma cells through inhibition of Stat3 pathway

(2010) Keinosuke Ryu et al.   BMC CANCER

Development of curcumin as an epigenetic agent

(2010) Siqing Fu et al.   CANCER

Cepharanthine exerts antitumor activity on cholangiocarcinoma by inhibiting NF-κB

(2010) Wunchana Seubwai et al.   CANCER SCIENCE

Dangerous liaisons: STAT3 and NF-κB collaboration and crosstalk in cancer

(2009) Sergei I. Grivennikov et al.   CYTOKINE & GROWTH FACTOR REVIEWS

IKK/NF-κB and STAT3 pathways: central signalling hubs in inflammation-mediated tumour promotion and metastasis

(2009) Julia Bollrath et al.   EMBO REPORTS

Biscoclaurine alkaloid cepharanthine inhibits the growth of primary effusion lymphomain vitroandin vivoand induces apoptosisviasuppression of the NF-κB pathway

(2009) Naoko Takahashi-Makise et al.   INTERNATIONAL JOURNAL OF CANCER

Cepharanthine inhibits angiogenesis and tumorigenicity of human oral squamous cell carcinoma cells by suppressing expression of vascular endothelial growth factor and interleukin-8

(2009) Harada   INTERNATIONAL JOURNAL OF ONCOLOGY

The gp130/STAT3 signaling pathway mediates β-adrenergic receptor-induced atrial natriuretic factor expression in cardiomyocytes

(2008) Hui Zhang et al.   FEBS Journal